EYES


Second Sight Medical Products Inc (EYES) to Initiate Study of Argus II in Better-Sighted Retinitis Pigmentosa Patients; Shares Rose 5%

Second Sight Medical Products Inc (NASDAQ:EYES) shares are up nearly 6% this morning, following the news that the company has received approval from …

Second Sight Medical Products Inc (EYES) Receives FDA Conditional Approval to Begin a Feasibility Study of Its Orion Cortical Visual Prosthesis System

Second Sight Medical Products Inc (NASDAQ:EYES) announced that the Company has received conditional approval from the FDA to begin the Orion™ Cortical Visual Prosthesis …

Second Sight Medical Products Inc’s (EYES) Argus II Retinal Prosthesis System Implanted in First Patient in Asia; Shares Rise Over 30%

Second Sight Medical Products Inc (NASDAQ:EYES) announced that the Argus® II Retinal Prosthesis System (Argus II) has been implanted in the first patient …

Company Update (NASDAQ:EYES): Second Sight Medical Products Inc Announces Positive Reimbursement Renewal Decision in Germany

Second Sight Medical Products Inc (NASDAQ:EYES) announced that the German Institute for the Hospital Remuneration System (InEK) has renewed Status 1 (full approval) …

Stock Update (NASDAQ:EYES): Second Sight Medical Products Inc Announces Rights Offering; Shares Dip 4%

Second Sight Medical Products Inc (NASDAQ:EYES) announced it filed a registration statement on Form S-1 with the Securities and Exchange Commission or a …

Company Update (NASDAQ:EYES): Second Sight Medical Products Inc Receives Funding from the UK Government for Argus II “Bionic Eye”

Second Sight Medical Products Inc (NASDAQ:EYES) announced, following a positive recommendation from advisors to the UK Government’s healthcare funding authority for specialized services …

Stock Update (NASDAQ:EYES): Second Sight Medical Products Inc Announces Successful Implantation and Activation of Wireless Visual Cortical Stimulator in First Human Subject

Second Sight Medical Products Inc (NASDAQ:EYES) announced the first successful implantation and activation of a wireless visual cortical stimulator in a human subject, providing …

Company Update (NASDAQ:EYES): Second Sight Medical Products Inc Announces Positive Five-Year Data from Argus II Retinal Prosthesis System

Second Sight Medical Products Inc (NASDAQ:EYES), the developer, manufacturer and marketer of implantable visual prosthetics that provide some useful vision to blind patients, …